XML 20 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Cash flows from operating activities:    
Net income for the period $ 979,657,000 $ 198,162,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization of intangible assets 242,644,000 179,806,000
Share-based compensation expense 22,373,000 19,080,000
Excess tax (benefits) on share-based compensation expense (1,586,000) (257,000)
Pension expense 2,953,000 3,459,000
Amortization of debt issuance costs 3,781,000 3,470,000
Amortization of deferred charges and credits 6,438,000 7,250,000
Loss on sale and write down of property and equipment 0 1,108,000
Deferred taxes (890,244,000) (15,692,000)
Share in net (income) of equity investees (6,153,000) 0
Write off of unamortized debt issuance costs 833,000 0
Other non-cash charges 1,033,000 0
Changes in operating assets and liabilities:    
Accounts receivable (37,095,000) 22,152,000
Prepaid expenses and other current assets (6,234,000) (2,589,000)
Income taxes and deferred charges and credits 1,570,000 3,290,000
Accounts payable and accrued liabilities 16,521,000 (27,434,000)
Deferred revenue 6,917,000 12,564,000
Other assets (6,635,000) 2,233,000
Net cash provided by operating activities 336,773,000 406,602,000
Cash flows from investing activities:    
Additions of property and equipment (50,071,000) (48,897,000)
Proceeds from maturity of short-term investments 9,212,000 9,239,000
Other investing activities (3,013,000) (6,124,000)
Net cash used in investing activities (2,158,519,000) (81,572,000)
Cash flows from financing activities:    
Excess tax benefits on share-based compensation expense 1,586,000 257,000
Proceeds from issuance of long-term debt (note 10) 256,875,000 0
Proceeds from revolver (note 10) 225,000,000 0
Proceeds from issuance of Common Shares from exercise of stock options and ESPP 26,668,000 11,828,000
Proceeds from issuance of Common Shares under the public Equity Offering 604,223,000 0
Repayment of long-term debt and revolver (5,940,000) (6,000,000)
Debt issuance costs (6,200,000) 0
Equity issuance costs (19,472,000) 0
Payments of dividends to shareholders (85,953,000) (71,627,000)
Net cash provided by (used in) financing activities 992,542,000 (141,678,000)
Foreign exchange (loss) on cash held in foreign currencies (5,553,000) (5,946,000)
Increase (decrease) in cash and cash equivalents during the period (834,757,000) 177,406,000
Cash and cash equivalents at beginning of the period 1,283,757,000 699,999,000
Cash and cash equivalents at end of the period 449,000,000 877,405,000
Common Shares    
Cash flows from financing activities:    
Common Shares repurchased 0 (65,509,000)
Treasury Stock    
Cash flows from financing activities:    
Common Shares repurchased (4,245,000) (10,627,000)
ECD Business    
Cash flows from investing activities:    
Purchase of business, net of cash acquired (1,622,394,000) 0
HP Inc. CCM Business    
Cash flows from investing activities:    
Purchase of business, net of cash acquired (315,000,000) 0
Recommind Inc    
Cash flows from investing activities:    
Purchase of business, net of cash acquired (170,107,000) 0
CEM Business    
Cash flows from investing activities:    
Purchase of business, net of cash acquired (7,289,000) 0
ANXeBusiness Corp.    
Cash flows from investing activities:    
Purchase of business, net of cash acquired 143,000 0
Daegis Inc.    
Cash flows from investing activities:    
Purchase of business, net of cash acquired 0 (22,146,000)
Acquisitions Prior to Fiscal 2016    
Cash flows from investing activities:    
Purchase of business, net of cash acquired $ 0 $ (13,644,000)